MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Prevalence of burning mouth syndrome in Parkinson disease

    X.X. Yu, H. Fernandez (Cleveland, OH, USA)

    Objective: 1. To estimate the prevalence of BMS in PD patients, compared with healthy controls.2. To identify potential factors associated with the presence or severity…
  • 2017 International Congress

    Tyrosine kinase inhibition clears Tau and reserves neuropathology and motor symptoms in a novel model of progressive supranuclear palsy

    Y. Torres-Yaghi, F. Pagan, A. Lawler, T. Kimbason, N. Starr, B. Wilmarth, M. Arellano, M. Javidnia, M. Hebron, C. Moussa (Washington, DC, USA)

    Objective: Our objective was to examine the effects of tau accumulation in transgenic mice, observing both motor function and behavior.  Background: Tau hyper-phosphorylation is a…
  • 2017 International Congress

    Differential diagnosis of Parkinson’s Disease and Progressive Supranuclear Palsy

    Y. Trufanov (Kyiv, Ukraine)

    Objective: The description of differential diagnostic features of PSP and PD in order to improve the diagnosis and the differential diagnosis of these diseases. Background:…
  • 2017 International Congress

    An evaluation of the diagnostic utility of radiological biomarkers in PSP

    J. Whitwell, G. Hoglinger, A. Antonini, Y. Bordelon, A. Boxer, C. Colosimo, R. Dodel, T. van Eimeren, L. Golbe, J. Kassubek, C. Kurz, I. Litvan, A. Pantelyat, G. Respondek, G. Rabinovici, J. Rowe, M. Stamelou, K. Josephs (Rochester, MN, USA)

    Objective: To critically evaluate the degree to which structural and molecular radiologic metrics fulfill criteria for diagnostic biomarkers of progressive supranuclear palsy (PSP). Background: PSP…
  • 2017 International Congress

    Movement Disorder Society – Clinical Diagnostic Criteria for Progressive Supranuclear Palsy

    G. Höglinger, G. Respondek, M. Stamelou, C. Kurz, K. Josephs, A. Lang, B. Mollenhauer, U. Müller, C. Nilsson, J. Whitwell, A. Boxer, L. Golbe, I. Litvan (Munich, Germany)

    Objective: The International Parkinson and Movement Disorders Society-endorsed PSP Study Group aimed to provide an evidence- and consensus-based revision of the clinical diagnostic criteria for…
  • 2017 International Congress

    Epidemiological profile of parkinsonism in a tertiary neurological clinic in the northeast of Brazil.

    R. Prado, P. Macêdo, A. Santiago, R. Sá, J. Santos, M. Machado (Aracaju, Brazil)

    Objective: To identify the epidemiological profile of patients with parkinsonism in a tertiary movement disorders clinic in the northeast of Brazil.To identify the epidemiological profile…
  • 2017 International Congress

    The diagnostic challenges of patients with possible multiple system atrophy

    M. Gultekin, R. Baydemir, M.F. Gol, M. Mirza (Kayseri, Turkey)

    Objective: The aim of the this study to review the diagnostic challenges of MSA and to evaluate the patients with different clinic types of MSA-…
  • 2017 International Congress

    Impact of levodopa-induced dyskinesias on Health-related Quality of Life. Results from the French COPARK study.

    S. Perez-Lloret, L. Negre-Pages, P. Damier, A. Delval, P. Derkinderen, A. Destée, W. Meissner, F. Tison, O. Rascol (Buenos Aires, Argentina)

    Objective: To assess the impact of LIDs on HRQoL in this large sample of unselected Parkinson’s Disease (PD) patients and to assess the factors related…
  • 2017 International Congress

    Neurogenic Orthostatic Hypotension Burden of Illness Patient and Caregiver Survey: Impact of Symptoms

    D. Claassen, C. Adler, C. Gibbons, L.A. Hewitt (Nashville, TN, USA)

    Objective: To determine the impact of neurogenic orthostatic hypotension (nOH) on the quality of life (QoL) of patients with autonomic dysfunction and the burden on…
  • 2017 International Congress

    Implanted Brain-Computer Interface for communication in people with motor impairment

    E. Pels, E. Aarnoutse, M. Vansteensel, S. Leinders, Z. Freudenburg, M. Branco, M. Vanden Boom, T. Denison, N. Ramsey (Utrecht, Netherlands)

    Objective: In people with movement disorder communication can be challenging and depends heavily on their caregiver. Here we describe an ALS-patient utilizing the first fully…
  • « Previous Page
  • 1
  • …
  • 116
  • 117
  • 118
  • 119
  • 120
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley